-The Times of India NEW DELHI: The World Health Organisation's (WHO) work of setting up norms and standards for production of medicines seems to be flawed by a fundamental conflict of interest. At the heart of its standard setting work is an entity the International Conference on Harmonization (ICH) in which majority of the WHO member countries have no voting rights and which is dominated by pharmaceutical industry groups. This glaring...
More »SEARCH RESULT
For shifting from paddy to cotton, 4,000/acre subsidy -Gurpreet Singh Nibber
-The Hindustan Times Chandigarh: The government of Punjab has decided to offer a subsidy of 4,000 per acre to motivate farmers to shift from the water-guzzling coarse rice variety (paddy) to the traditional cash crop cotton. In the crop diversification plan, the government has decided to initially support 1,500 acres in Abohar, Fazilka, Malout, Maur and Muktsar. CM Parkash Singh Badal cleared the plan on Monday. The subsidy is for purchasing hybrid...
More »Onus on the state-Sagnik Dutta
-Frontline A Delhi High Court verdict says the State government is bound to ensure that poor and vulnerable sections of society have access to treatment for rare and chronic diseases. SEVEN-YEAR-OLD Mohammed Ahmed Khan looked on helplessly as his father, Sirajuddin, narrated the sordid tale of the loss of four of his children to Gaucher's disease, a rare genetic disease that requires lifelong, exorbitantly expensive enzyme replacement therapy. Sirajuddin, a rickshaw...
More »Justice still denied
-The Business Standard Higher judiciary has not addressed the delays in India's courts Continuing what will be a year of quick personnel changes for the higher judiciary, a new chief justice of India, R M Lodha, has taken office. Justice Lodha will have only a five-month tenure. It will be difficult for him to introduce any far-reaching reform in this period. His initial speech after being sworn in must have been written...
More »SC ruling on clinical trials
-The Telegraph New Delhi: The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India. A bench of Justices R.M. Lodha and Kurien Joseph, responding to a public interest petition by a non-government organisation called Swasthya Adhikar Manch, also told the Centre to ensure that the candidate compounds...
More »